Verdence Capital Advisors LLC Adamis Pharmaceuticals Corp Transaction History

Verdence Capital Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$0.55 - $0.73 $46,750 - $62,050	-85,000 Reduced 59.28%	58,382 $33,000
Q2 2021 Aug 06, 2021	BUY	$0.66 - $1.23 $56,100 - $104,550	85,000 Added 145.59%	143,382 $158,000
Q4 2020 Feb 12, 2021	SELL	$0.4 - $1.01 $12,000 - $30,300	-30,000 Reduced 33.94%	58,382 $28,000
Q3 2020 Nov 09, 2020	BUY	$0.52 - $1.45 $45,958 - $128,153	88,382 New	88,382 $69,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Verdence Capital Advisors LLC with notifications on news.